Encapsulation of irinotecan in polymeric nanoparticles: Characterization, release kinetic and cytotoxicity evaluation

Publish Year: 1395
نوع سند: مقاله ژورنالی
زبان: English
View: 348

This Paper With 10 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_NAMJ-3-3_003

تاریخ نمایه سازی: 18 تیر 1398

Abstract:

Objective(s): Irinotecan is a potent anti-cancer drug from camptothecin group which inhibits topoisomerase I. Recently, biodegradable and biocompatible polymers such as poly lactide-co-glycolides (PLGA) have been considered for the preparation of nanoparticles (NPs). Materials and Methods: In this study, irinotecan loaded PLGA NPs were fabricated by an emulsification/solvent diffusion method to improve the efficacy of irinotecan. The effect of several parameters on the NPs’ characteristics was assessed, including the amount of drug and polymer, the amount and volume of the poly vinyl alcohol as a surfactant, and also the internal-phase volume/composition. The irinotecan entrapment efficiency and the particle size distribution were optimized by changing these variables. The cytotoxicity of the particles was evaluated by cell viability assay.Results: NPs were spherical with a comparatively mono-dispersed size distribution and negative zeta potential. Selected formulation (S9) showed suitable size distribution about120 nm with relative high drug entrapment. MTT assay showed a stronger cytotoxicity of S9 against HT-29 cancer cells than control NPs and irinotecan free drug. The release kinetic indicated Log-Probability model in S9.Conclusion: Our results demonstrated that the designed NPs show suitable characteristic and also great potential for further in vivo cancer evaluation.

Authors

Heydar Mohammady

Novel Drug Delivery Systems Lab, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Rassoul Dinarvand

Novel Drug Delivery Systems Lab, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran|Medical Nanotechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran , Iran

Mehdi Esfandyari Manesh

Novel Drug Delivery Systems Lab, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran|Medical Nanotechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran , Iran

Pedram Ebrahimnejad

Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran|Pharmaceutical Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Mathieson RHJ, Loos WJ, Verweij J and Sparreboom A. Pharmacology ...
  • Mohajer M, Khameneh B, Tafaghodi M. Preparation and characterization of ...
  • Onishi H, MachidaYandMachidaY. Antitumor properties of irinotecan-containing nanoparticles prepared using ...
  • Ebrahimnejad P, Dinarvand R, Sajadi SA, Jafari MR, Movaghari F, ...
  • Kunii R, Onishi H, Ueki K, Koyama K, Machida Y. ...
  • Ebrahimnejad P, Dinarvand R, Sajadi SA, Atyabi F, Ramezani F, ...
  • Oguma T. Antitumor drug processing topoisomerase I inhibition: applicable separation ...
  • Sano K, Yoshikawa M, Hayasaka S, Satake K, Ikegami Y, ...
  • Esmaeili F, Atyabi F, Dinarvand, R. Preparation and characterization of ...
  • Kim SH, Jeong JH, Chun KW, Park TG, Target-specific cellular ...
  • Ebrahimnejad P, Dinarvand R, Sajadi A, Jaafari MR, Nomani AR, ...
  • Singh R, Jr JWL. Nanoparticle-based targeted drug delivery. Exp Mol ...
  • Paruchuri R, Trivedi Sh, Joshi SV, Pavuluri G, Kumar MS. ...
  • Danhier F, Lecouturier N, Vroman B, Jérôme C, Marchand-Brynaert J, ...
  • Mohammadi A, Esmaeili F, Dinarvand R, Atyabi F, Walker RB. ...
  • Peppas NA. Analysis of fickian and non-fickian drug release from ...
  • Barzegar-Jalali, M. Kinetic analysis of drug release from nanoparticles. J ...
  • Arica B, Lamprecht A. In vitro evaluation of betamethasone-loaded nanoparticles. ...
  • Sharma A, Pandey R, Sharma S, Khuller GK. Chemotherapeutic efficacy ...
  • Alex R, Bodmeier R. Encapsulation of water-soluble drugs by a ...
  • Loveymi BD, Jelvehgari M, Zakeri-Milani P, Valizadeh H. Statistical Optimization ...
  • Guo S, Zhang X, Gan L, Zhu C, Gan Y. ...
  • Ricci M, Blasi P, Giovagnoli S, Perioli L, Vescovi C, ...
  • Kato K, Chin K, Yoshikawa T, Yamaguchi K, Tsuji Y, ...
  • Tian G, Zheng X, Zhang X, Yin W, Yu J, ...
  • Acharya S, Sahoo SK. PLGA nanoparticles containing various anticancer agents ...
  • Liu Y, Schwendeman SP. Mapping microclimate pH distribution inside protein-encapsulated ...
  • Tacar O, Sriamornsak P, Dass CR. Doxorubicin: an update on ...
  • Mosallaei N, Jaafari MR, Hanafi Bojd MY, Golmohammadzadeh S, Malaekeh ...
  • نمایش کامل مراجع